HOPES: A QUALITY OF LIFE TOOL FOR HIV (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HOPES: A QUALITY OF LIFE TOOL FOR HIV (MEETING ABSTRACT)

Proc Annu Meet Am Soc Clin Oncol; 11:A11 1992. Unique Identifier : AIDSLINE ICDB/92680742
Schag CA; Ganz PA; Kahn B; Petersen L; Dept. of Medicine, UCLA, Los Angeles, CA 90024

Abstract: Quality of life (QL) in patients (pts) with HIV infection and its sequelae are of increased concern as pts live for longer periods of time. The Cancer Rehabilitation Evaluation System (CARES) is a detailed cancer-specific QL assessment tool with excellent psychometric properties that we adapted for HIV pts: the HOPES (HIV Overview of Problem Situations-Evaluation System). In preliminary analysis of a sample of 106 HIV-infected pts (24% HIV+ asymptomatic, 15% ARC, 40% AIDS, 21% AIDS with cancer), its psychometric properties are excellent. Internal consistency coefficients of its 35 subscales range from 0.68-0.96 with a mean of 0.85 and is comparable to the CARES. The pattern of correlations, as shown in a table, of the HOPES summary scores with other measures provide evidence of the HOPES' validity. In this sample, 70% or more indicated problems with ambulation, recreation, work, pain, body image stigma, psychological distress, communication with friends/family, worry, sexual activity, and new relationships. The data support the HOPES as a QL tool for HIV-infected pts.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/PHYSIOPATHOLOGY/ *PSYCHOLOGY/THERAPY Human HIV Infections/COMPLICATIONS/PHYSIOPATHOLOGY/*PSYCHOLOGY/THERAPY Neoplasms/ETIOLOGY/PSYCHOLOGY *Quality of Life Treatment Outcome ABSTRACT

KWDacquiredimmunodeficiencysyndrome/complications/physiopathology/KWDpsychology/therapyhumanhivinfections/complications/physiopathology/KWDpsychology/therapyneoplasms/etiology/psychologyKWDqualityoflifetreatmentoutcomeabstract
921130
M92B0898

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .